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Root of Gentiana lutea commercially available as gentian root, a natural antidote for different types of poisons, possess 
antioxidative, immunomodulatory, cytoprotective and anti-inflammatory, and adverse, genotoxic and mutagenic effects. It 
has monoterpenes loganic acid, swertiamarin, gentiopicroside and sweroside as most abundant constituents. In this study, 
we assessed the toxicity of monoterpenes’ reactive molecular fragments using in silico prediction by VEGA-QSAR 
platform. Further, we compared the data obtained with in vitro geno- and cyto- toxicity testing of the above monoterpenes 
and the G. lutea root extract (GE), on human primary unstimulated and mitogen-stimulated peripheral blood mononuclear 
cells (PBMCs). Viability was assessed by TB and XTT tests after 48 h treatment. DNA damage was evaluated by alkaline 
comet assay on unstimulated cells, whereas cytokinesis-block micronucleus assay was employed on mitogen-stimulated 
PBMCs. Stability of compounds throughout treatment was monitored by UPLC. The observed in vitro results had highest 
compliance with in silico IRFMN/ISSCAN-CGX prediction model. Compounds showed high stability during experiment 
while treatment with single compounds reduced number of viable cells and increased DNA damage. GE treatment had 
toxic impact on unstimulated PBMCs but no significant genotoxic influence on mitogen-stimulated PBMCs. In summary, 
the mild GE effect suggests that the complexity of crude GE extract chemical composition  may attenuate the toxicity of 
the tested monoterpenes loganic acid, swertiamarin, gentiopicroside and sweroside. 
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Gentiana lutea, also known as the yellow gentian, is a 
plant that belongs to the family of Gentianaceae 
widely distributed in the mountain regions of Europe, 
Southeast Asia, and North America. It is commonly 
used in traditional medicine, however root extract 
(GE), and its monoterpenes, including loganic acid 
(La), sweroside (Sw), gentiopicroside (Gp), and 





 exert detrimental, 
genotoxic
5
, mutagenic and clastogenic effects
6,7
. For 
instance, depending of experimental conditions, 





 and damaging outcomes
6
, while 
sweroside and swertiamarin, which are present in 
lower amounts than gentiopicroside, manifest non-
toxic
10,11
 to noticeably cytotoxic effects
12
. Although 
listed monoterpenes share structural similarity, the 
slight differences in their structure may influence 
intensity of toxic potential
13
. 
Toxicology assessment software offers rapid 
evaluation of chemical toxicity considering different 
toxicological endpoints and/or metabolic pathways. 
Two main approaches for the assessment of 
compounds’ toxicity are mostly used, Read-across 
and Quantitative Structure-Activity Relationship 
(QSAR)
14,15
. VEGA-QSAR platform combines both 
approaches, offering prediction for a number of 
outcomes through QSAR prediction models
16
. VEGA-
QSAR provides five models for mutagenicity, four for 
carcinogenicity effect prediction and an independent 
algorithm for the evaluation of the result through the 
Applicability Domain Index (ADI)
15,16
. Genotoxicity 
and cancerogenicity correlates in aspects like 
chromosomal instability and unrepaired DNA 
damage
17,18
. Data of carcinogenic potency and cell 
viability studies originated from high-throughput 
screening (HTS) of environmental chemicals reveal 
that chemicals which affect cell viability are likely to 
be carcinogens
19
. Thus, VEGA-QSAR models’ 
prediction of mutagenic and carcinogenic compounds’ 
effects, could reflect both on geno- and cyto- toxicity 
outcomes
20
. Literature search suggests that the 
toxicity assessment obtained by in silico prediction 










As exposure to chemicals in vivo leads to elevated 
concentrations of unchanged compounds and their 
metabolized products in peripheral blood, the 
peripheral blood mononuclear cells (PBMCs) are 
adequate and often used model system in toxicological 
studies
22-24
. A part of PBMCs, T lymphocytes, can be 
transformed into blast forms with phytohemagglutinin 
(PHA), and hence this model system enables testing on 
differentiated and dividing cells of the same origin. 
Since PHA-stimulated PBMCs exibit higher level of 
repair capacity compared to unstimulated, their parallel 




Here, we investigated monoterpene constituents of 
gentian root (Gentiana lutea) and their previously 
reported GE effects. We selected monoterpenes with 
possible toxic effects tested using the in silico toxicity 
analysis and monitored chemical stability during the 
treatment to confirm that the recorded effect due to the 
presence of these compounds, and further compared 
the in silico and in vitro results. 
 
Materials and Methods 
 
Chemicals/reagents 
Commercially available Gentiana lutea L radix 
(Gentian root) was purchased from the Institute of 
Medicinal Plant Research “Dr Josif Pancic”, Belgrade, 
Republic of Serbia (Product safety and quality 
management policy: SPRS ISO 9001:2015; codex 
alimentarius [CAC/RCP 1-1969, rev. 4-2003)]. 
Chemicals used for cell cultures were acquired from 
Capricorn Scientific GmbH (Ebsdorfergrund, 
Germany) and reference compounds were from Wuhan 
ChemFaces Biochemical Co (Wuhan, PRC). Trypan 
blue (TB), sodium 3,3'-{-[(phenylamino)carbonyl]-3,4-
tetrazolium}-Bis(4-methoxy-6-nitro) benzenesulfonic 
acid hydrate (XTT), phenazinemethosulfate (PMS), all 
used in viability assays were purchased from Serva 
(Heidelberg, Germany). Low melting point agarose 
(LMPA), normal melting point agarose (NMPA), 
cytochalasin B, Giemsa stain, 4′,6-diamidino-2-
phenylindole dihydrochloride (DAPI), analytical grade 
salts, solvents and buffer reagents were purchased from 
Sigma-Aldrich Co (St Louis, MO, USA). Vectashield 




For in silico analysis of the most common GE 
constituents (loganic acid, swertiamarin, gentiopicro- 
side and sweroside) we used VEGA-QSAR software 
(http://www.vega-qsar.eu/)
16
. Namely, by inserting 
chemical structure of interest in the form of the 
simplified molecular-input line-entry system 
(SMILES) and selecting Tox models, VEGA-QSAR 
software provided us numerous information about 
compounds’ structure related effects. Among them 
were structural alerts (SAs) in chemical structure of 
tested compounds, based on analogy with known 
mutagenic and cancerogenic chemicals of similar 
structure. Additionally, software incorporated 
algorithm gave evaluation of reliability prediction as 
ADI value. We used positive results with ADI >0.5, 
as indicators of potential toxicity effect: low (0.5 
<ADI <0.6), medium (0.6 <ADI <0.8) and high (0.8 
<ADI <1). 
 
Preparation of GE 
Aqueous extract was prepared by heating ground 
G. lutea root (GE) in water, for 10 min, in ratio 1:5 
(m/V). GE was filtered using Whatman Filter paper 
No.4 (GE Healthcare Life Sciences, MA, USA), 
supernatant was centrifuged at 10000 ×g for 20 min to 
separate non-soluble particles, lyophilized and stored 
in sample tubes at 4°C until use. Prior to analysis 
lyophilized powder was dissolved in 50% ethanol to 
obtain concentration 50 mg/mL, passed through  
0.2 μm Minisart filter (Göttingen, Germany) and used 
as a stock solution in further experiments. 
 
Chromatographic analysis  
Waters ACQUITY Ultra Performance Liquid 
Chromatography (UPLC) system (Malvern 
Panalytical Ltd, Malvern, UK) with PDA detector and 
LUNA 3u, C18(2), 3 μm, 100 × 2 mm Phenomenex 
column (BO, Italy), as a stationary phase, was used 
for chromatographic separations. All analyses were 
done under gradient condition with mobile phase 
consisting of solvent A (0.1 wt.%HCOOH in water) 
and solvent B (0.1 wt.%HCOOH in methanol) at a 
constant flow rate of 0.3 mL/min. The solvent B 
content was changed from 5 to 55% up to 8 min, from 
8-8.2 min the proportion of solvent B was decreased 
back to the starting and held constant up to 9 min. 
Autosampler and column compartment were 
maintained at 4 and 35°C, respectively. The 3D 
chromatograms were recorded in wavelength range 
from 210 to 500 nm and 2D chromatograms at 
254 nm (for all reference compounds) and 
additionally at 271 nm for gentiopicroside. The run 
time was 9 min and injection volume 2-6 µL. 
Standard solutions of all investigated reference 
compounds (loganic acid, swertiamarin, gentiopicroside 




and sweroside) were prepared for construction of 
calibration curve by dissolving 5 mM stock solutions 
in cell culture medium (concentration range from 25 
to 50 µM). GE solution in concentration 1.0 mg/mL 
was used for quantification. Chromatograms of tested 
compounds in cell culture medium were recorded at 
the beginning (0 h) and end of treatment (48 h) to 
determine their stability at 37°C. Additionally, we 
analyzed media originated from both type of PBMCs 
cultures after 48 h of treatment. To provide clear 
samples, we precipitated serum proteins with HCl 
solution at final concentration 0.3% and 
centrifugation at 8000×g (Eppendorf AG, Hamburg, 
Germany). Furthermore, we tested the stability of 
compounds by titration to neutral pH with NaOH in a 
10 mM final concentration. 
 
Cell culture 
Heparinized blood samples were obtained from 
healthy donors aged 20-40 years with informed 
consent. PBMCs were isolated using separation 
solution made with Ficoll™ density gradient media 
according to the manufacturer’s instructions. Cells 
were cultured in RPMI 1640, supplemented with 1% 
penicillin–streptomycin, 10% fetal bovine serum for 
all and 3% PHA–M solution for stimulated cultures. 
Reference compounds were dissolved in 50% ethanol 
to obtain 5 mM stock solutions. 
 
PBMCs were resuspended in culture medium at a 
concentration of 1 × 10
6
 viable cells/mL, treated with 
50 µM reference compounds or 1.0 mg/mL GE, and 
placed in an incubator for 48 h at 37°C. At the end of 
the treatment, cultured cells were divided and used for 
viability and genotoxicity assays, while supernatant 
was aliquoted for chromatographic analysis. 
 
Viability tests 
Selection of optimal dose for in vitro treatments 
was performed by cell viability test (TB) employing 
different concentrations of plant extract (0.1-2 mg/mL) 
and single compounds (20-130 µM), on primary 
unstimulated PBMCs for 48 h. For TB assay, 100 µL 
of PBMC cell culture was mixed with the same 
volume of 0.4% TB suspension was counted using a 
haemocytometer (Cambridge Instruments Inc. NY, 
USA). Cell counting and calculation of number of 
viable cells in samples were performed according to 
Strober
25
. Concentration of compound with lowest 
toxic effect, that significantly reduced number of 
viable cells after 48 h treatment, was chosen as  
further equimolar treatment concentration. Equimolar 
concentration of single compounds was used to 
discriminate some SAs or to validate cumulative 
effect of other. 
 
Cell viability after 48 h treatment was assessed 
with TB and XTT viability assay. For XTT assay, 50 µL 
(1.0 mg/mL) of reagent activated with PMS was 
added to 100 µL aliquot of cultured cells per well and 
put in incubator at 37°C, for 2-4 h until development 
of colour. Colorimetric measurements were performed 
at 470 nm with cut off at 660 nm, using a Sunrise 
microplate reader apparatus (Tecan Group Ltd, 
Männedorf, Switzerland).  
 
Alkaline comet assay 
Alkaline comet assay was performed using an 
adaptation of the method of Singh et al
26
. In brief, 
after 48 h of treatment, PBMCs were washed in 1×PBS, 
suspended in 1% LMPA in PBS, pH 7.4, at 37°C, and 
100 µL were pipetted onto a glass microscope slide pre-
coated with 100 µL layer of 1% NMPA. Slides were put 
at 4°C for 10 min for agarose to set, and then immersed 
in lysis solution (2.5 M NaCl, 100 mM Na2EDTA,  
10 mM Tris, NaOH to pH 10.0, and 1% Triton X-100) 
at 4°C for 1 h. Slides were then placed in an electro-
phoresis tank containing 0.3 M NaOH and 1 mM 
Na2EDTA, pH >13, for 20 min before electrophoresis. 
Electrophoresis was done at 25V (1 V/cm, 300 mA) for 
20 min at 4°C. Slides were then washed 3 times for  
5 min, each with 0.4 M Tris-HCl, pH 7.5, at 4°C, dried 
and counterstained with (DAPI)-containing Vectashield 
solution (5 µg/mL). For each slide at least 300 cells were 
evaluated for the percentage of DNA in the comet tail 
using Zeiss-Axioimager A2 microscope with automated 




The CBMN assay was performed as described by 
Fenech
27
. Slides were scored using an Axioimager 1 
(Carl Zeiss, Jena, Germany), light optical microscope 
with magnification 400X, following the scoring criteria 
outlined by the International Human Micronucleus 
(HUMN) Project
28
. Each sample was evaluated for the 
frequency of micronuclei (MNi-BN) and CBPI. 
 
Statistical analysis 
All experimental procedures were performed at 
least three times in duplicate and data were expressed 
as mean±SEM. Statistical significance was assessed 
by One-Way ANOVA accompanied by Tukeys’ post 
hoc test, using software SPSS for Windows 10.0. All 
results were considered significant at P <0.05. 






Positive results of VEGA-QSAR in silico 
prediction of tested compounds are presented in  
Table 1 and Fig. 1. VEGA-QSAR models, used for  
in silico mutagenic and carcinogenic prediction, 
marked structural alerts (SAs) number 29 and 76 in all 
analyzed molecules. Small differences in molecular 
structure of tested compounds were presented as 
additional SAs for loganic acid (La) (No 106) and 
gentiopicroside (Gp) (No 13, SM 55) (Fig. 1). From 
five mutagenicity models, only CAESAR 2.1.13 
marked La as potential mutagen (ADI >0.8). 
Mutagenicity predictions for other tested compounds, 
in all models, were inconclusive since both positive 
and negative predictions were out of highly reliable 
AD. Carcinogenicity models CAESAR (2.1.9) and 
ISS (1.0.2) predicted non-carcinogenic effect of 
examined compounds with medium to high AD, while 
other two carcinogenicity models, IRFMN/Antares 
and IRFMN/ISSCAN-CGX, had opposite predictions 
(Table 1). 
 
Quantitative UPLC analysis of Gentiana lutea root 
extract (GE) in medium is given in Table 2. 
Identification of peaks in GE chromatograms was 
performed by comparing their retention times and 
correspondent UV spectra with reference compounds, 
according to the calibration curves. Although 
retention times for Gp and sweroside (Sw) solutions 
in medium are similar, better resolution could be 
achieved through comparative analysis of  
chromatograms extracted at 254 and 271 nm (Fig. 2). 
Peak area corresponding to Sw is much lower for 
chromatogram recorded at 271 nm (Fig. 2B), while 
for Gp, peak area obtained at 271 nm (Fig. 2D) is 
higher than in the case of 254 nm (Fig. 2C). 
 
As presented in Fig. 3, UPLC analysis of control 
GE treatment medium after 48 h, compared with 
initial condition, displayed stability of tested 
compounds. Analyses of complete cell culture 
medium, after 48 h of PBMCs cultivation with 
compounds, showed substantial change in 




Fig. 1 — SAs of tested compounds marked by VEGA-QSAR 




Fig. 2 — UPLC chromatograms of (A & B) Swertiamarin (Sm) ; 
and (C &D) Gentiopicroside (Gp) in medium recorded at 254 and 
271 nm, respectively. [injection volume 6 µL; * peak corresponds 
to mediums’ constituents] 
 
Table 2 — Quantitative analysis of Gentiana lutea root extract 









(M×10-6) (min) (%) 
Loganic acid 57.6±2.4 2.4±0.1 2.17±0.08 





Swertiamarin 16.1±0.6 3.0±0.1 0.60±0.02 
 
Table 1 — Positive prediction reliability of VEGA-QSAR models [Applicability Domain Index (ADI) values] 
 
Loganic acid Sweroside Gentiopicroside Swertiamarin 
Mutagenicity (CAESAR) 2.1.13 0.818*** - - - 
Mutagenicity (SarPy/IRFMN) 1.0.7 - - 0.519* - 
Carcinogenicity (IRFMN/Antares) 1.0.0 0.744** 0.616** 0.612** 0.521* 
Carcinogenicity (IRFMN/ISSCAN-CGX) 1.0.0 0.797** 0.802*** 0.802*** 0.798** 
[*low reliability prediction; **medium reliability prediction; and ***high reliability prediction] 
 




constituents were eluted simultaneously with Gp and 
Sw with no change in retention times (Fig. 4B). 
In primary unstimulated PBMCs, treatments with 
50 µM of single compounds and treatment with GE at 
concentration of 1.0 mg/mL, significantly decreased 
number of viable cells (P <0.05, df=5, F=21.5) 
compared to control (Fig. 5A). Gp and Sw reduced 
the number of viable cells for 25%, standing out as 
more toxic than other tested compounds (Tukeys’ 
subset 1=1, α=0.05). Moreover, all investigated single 
compounds significantly reduced the number of 
viable PHA-stimulated PBMCs compared to control, 
 
 
Fig. 4 — UPLC chromatograms of reference compounds and GE 
recorded at 254 nm, after 48 h lasting treatment: (A) control 
medium; and (B) PBMCs treatments. [0, medium; 1, Loganic acid 
(La); 2, Swertiamarin (Sm); 3, Gentiopicroside (Gp); 4, Sweroside 
(Sw); GE, Gentiana lutea root extract; injection volume 4.5 µL; * 




Fig. 3 — UPLC chromatograms of medium with Gentiana lutea 
root extract (GE) (1 mg/mL) from time points 0 h (solid lines) and 





Fig. 5 — (A) Viability presented as number of cells after 48 h treatment in unstimulated and PHA-stimulated PBMCs; (B) Comet test 
results presented as % of DNA in comet tail; (C) Micronucleus test presented as a number of MNi/1000 binucleated cells; and  
(D) Proliferation potential (CBPI) of PHA-stimulated PBMCs. [*P <0.05 vs. 0 µL/mL] 
 




ranging from 13 to 16% (P <0.05, df=5, F=10.1), with 
no compound standing out as more toxic. In contrast, 
PHA-stimulated PBMCs treatment with GE, had 
number of viable cells in the range of control 
(Tukeys’ subset 2=0.89, α=0.05). 
A significant percentage of DNA in comet tail of 
primary unstimulated PBMCs, induced by all 
compounds and GE, was detected when compared to 
control (P <0.05, df=5, F=12.8) (Figs 5B & 6). The 
DNA damage induced by Sw and Gp, was more than  
6- to 5-fold higher than control, while loganic acid (La), 
swertiamarin (Sm) and gentian root extract (GE) effect 
was 4-fold higher than control. Significant negative 
correlation between percentage of DNA in comet tail 
and number of viable cells in primary unstimulated 
treated cells was noted (r=0.488, P <0.05). 
CBMN assay showed that GE had no influence on 
MNi frequency, while all single compounds elevated 
them in comparison to control (P <0.05, df=5, 
F=39.7). Gp, Sw, La and Sm treatments increased 
MNi frequencies 3.5-fold, 2.7-fold, 2.4-fold and  
1.9-fold, respectively (Fig. 5C). As illustrated in  
Fig. 5D, proliferative capacity of stimulated cells 
(CBPI), was significantly reduced by all compounds 
and GE, compared to control (P <0.05, df=5, 
F=101.5), in range from 16% for Sw to 11% for GE 
(Fig. 5D). CBPI negatively correlates with MNi 
frequency (r=0.715, P <0.05). 
 
Discussion 
Quantitative analysis of gentian root extract (GE) 
showed high content of gentiopicroside (Gp) (20%) 
(Table 2) which is in an accordance with the other 
studies that also reported its high concentration
29-31
. 
All investigated compounds showed high stability 
considering temperature and time of exposure (37°C, 
48 h), presented as overlap of chromatograms recorded 
in control medium with GE at 0 and 48 h (Fig. 3). 
Chromatograms of medium after 48 h of PBMCs 
cultivation showed that all compounds were present 
although unsuitable for quantification, most likely due 
to chromatograms complexity (Fig. 4B). To gain 
precise overview of cell culture activity more 
extensive analysis is required. 
In primary unstimulated PBMCs, upon treatment 
with single compounds, number of viable cells was 
lowered compared to control as in PHA-stimulated 
PBMCs. GE lowered the number of viable cells in 
primary cell cultures, while in PHA-stimulated its 
effect was in range of control (Fig. 5A). Disparity in 
response to treatments, presented as higher number of 
viable cells in stimulated cultures, might be due to 
different repair capacity between metabolically 
dormant and active cells
23-24
. Several studies reported 
that genes involved in repair had more than 2-fold 




All treatments on unstimulated PBMCs resulted in 
elevated percentage of DNA in comet tail, and 
lowered number of viable cells, pointing that 
accumulation of DNA damage over the treatment 
period, consequently induced cell death (Fig. 5 A & B). 
Also, observed negative correlation of proliferative 
capacity presented as CBPI value and MNi frequency, 
suggests that cell death and/or cytostasis could be due 





Interestingly, gentiopicroside (Gp) concentration 
in gentian root extract was 10 times higher than in Gp 
treatment with significant toxic effect (Table 2), 
indicating that single compounds have different effect 
than in crude extract. Mildest toxic effect of crude 
extract than its single constituents previously was 
explained as antagonistic effects of single compounds 
when they are present in the same mass 
concentration
34
. Phenolic, flavonoid and flavone 
fractions of GE and extracts of plant, in general, 
display significant antioxidant capacity. They could 
modify damaging influence of single compounds 
present in complex extracts, as are secoiridoids 
present in GE
35,36
. Mihailovic et al. suggested that 
bioactive compounds of GE act as bio-antimutagens 
expressing protective effects in a presence of mutation 
agent
37
. This mode of action does not exclude 






Fig. 6 — Representative images of DNA damage in primary 
unstimulated PBMCs presented as % of DNA in comet tail; (A) 
vehicle control; and (B-F) Loganic acid (La), Swertiamarin (Sm), 
Gentiopicroside (Gp), Sweroside (Sw) and Gentiana lutea root 
extract (GE) treatment, respectively 
 




Prior testing of IRFMN/ISSCAN-CGX 1.0.0, 
showed that this model achieved highest accuracy 
(75%) and sensitivity (82.6%), of all carcinogenicity 
models in VEGA-QSAR platform
39,40
. High 
sensitivity indicates its strong ability to accurately 
predict carcinogenic effects of chemicals
40
. 
IRFMN/ISSCAN-CGX 1.0.0 model marked Sw and 
Gp compounds as carcinogens with high reliability 
prediction (ADI >0.8), as confirmed by our 
experimental results (Table 1). La that was predicted 
as mutagen and carcinogen, with medium reliability, 
in our study induced higher frequency of MNi than 
Sm and GE treatment. Swertiamarin (Sm), estimated 
as carcinogen with low reliability, indeed showed 
lowest toxic influence compared to other tested 
compounds. In silico analysis marked Gp as a 
compound with numerous SAs, which is in a 
compliance with detected level of Gp toxicity (Fig. 1). 
Sweroside (Sw) and swertiamarin (Sm) have the same 
structural alerts (SAs) but different level of predicted 
as well as displayed toxicity, indicating that SAs 
could be used as indicators, rather than predictors, of 
potential toxicity
15
. Apart from the SAs, toxicity 
potential might be based on other biological or 
physical property influenced by small structural 





In the current study, toxicity of tested monoterpene 
compounds, documented by in silico analysis and in 
vitro testing, marked them as potential cause of GE 
detrimental effects. Treatment with these single 
compounds elevates DNA damage, seen as increment 
of micronuclei and percentage of DNA in the comet 
tail. This might be linked to the initiation and 
progression of cell death signalling cascade, although 
additional studies would elucidate precise mechanism 
of DNA strand brakes generation. Even though higher 
concentration of Gp in GE was present compared to 
single compound treatment, the effects on the cellular 
survival and DNA damage were milder. These results 
suggest that GE complex chemical composition could 
attenuate single compounds’ toxic effects, but their 
extent depends on cell repair ability. 
 
Informed consent 
Blood samples, used in this study, were obtained 
from healthy volunteers with informed consent. The 
study conformed to Declaration of Helsinki and was 
approved by Ethical Committee of the VINČA 
Institute of Nuclear Sciences, National Institute of the 
Republic of Serbia, University of Belgrade: Ethics 
committee approval no. 1109/1. 
 
Acknowledgement 
This study was supported by the Ministry of 
Education, Science and Technological Development of 
the Republic of Serbia (Grant No. 173046 and TR 
37021). 
 
Conflict of interest 
Authors declare no conflict of interests. 
 
References 
1 Mirzaee F, Hosseini A, Jouybari HB, Davoodi A & 
Azadbakht M, Medicinal, biological and phytochemical 
properties of Gentiana species. J Tradit Complement Med, 7 
(2017) 400. 
2 Joksic G, Radak D, Sudar-Milovanovic E, Obradovic M, 
Radovanovic J & Isenovic ER, Effects of Gentiana lutea root 
on vascular diseases. Curr Vasc Pharmacol, (2020) doi: 
10.2174/1570161118666200529111314.  
3 Azman NA, Segovia F, Martinez-Farre X, Gil E & Almajano MP, 
Screening of Antioxidant Activity of Gentiana Lutea Root 
and Its Application in Oil-in-Water Emulsions. Antioxidants 
(Basel), 3 (2014) 455. 
4 Gendrisch F, Nováčková A, Sochorová M, Haarhaus B, 
Vávrová K, Schempp CM & Wölfle U, Gentiana lutea 
Extract Modulates Ceramide Synthesis in Primary and 
Psoriasis-Like Keratinocytes. Molecules, 16 (2020) 1832. 
5 Patenković A, Stamenković-Radak M, Nikolić D, Marković T 
& Anđelković M, Synergistic effect of Gentiana lutea L. on 
methyl methanesulfonate genotoxicity in the Drosophila 
wing spot test. J Ethnopharmacol, 146 (2013) 632. 
6 Mustafayeva K, Di Giorgio C, Elias R, Kerimov Y, Ollivier E & 
De Meo M, DNA-damaging, mutagenic, and clastogenic 
activities of gentiopicroside isolated from Cephalaria 
kotschyi roots. J Nat Prod, 73 (2010) 99. 
7 Kesavan R, Potunuru UR, Nastasijević B, Avaneesh T, 
Joksić G & Dixit M, Inhibition of Vascular Smooth Muscle 
Cell Proliferation by Gentiana lutea Root Extracts. PLoS 
One, 8 (2013) e61393. 
8 Mustafa AM, Caprioli G, Ricciutelli M, Maggi F, Marín R, 
Vittori S & Sagratini G, Comparative HPLC/ESI-MS and 
HPLC/DAD study of different populations of cultivated, wild 
and commercial Gentiana lutea L. Food Chem, 174 (2015) 
426. 
9 Jin M, Feng H, Wang Y, Yan S, Shen B, Li Z, Qin H, Wang Q, 
Li J & Liu G, Gentiopicroside Ameliorates Oxidative Stress 
and Lipid Accumulation through Nuclear Factor Erythroid 2-
Related Factor 2 Activation. Oxid Med Cell Longev, 2020 
(2020) 2940746. 
10 Zhang M, Ma X, Xu H, Wu W, He X, Wang X, Jiang M, 
Hou Y & Bai G, A natural AKT inhibitor swertiamarin 
targets AKT-PH domain, inhibits downstream signaling, and 
alleviates inflammation. FEBS J, 287 (2020) 1816. 
11 Vaijanathappa J, Puttaswamygowda J, Bevanhalli R, Dixit S 
& Prabhakaran P, Molecular docking, antiproliferative and 




anticonvulsant activities of swertiamarin isolated from 
Enicostemma axillare. Bioorg Chem, 94 (2020) 103428. 
12 Ouyang Z & Xu G, Antitumor effects of Sweroside in human 
glioblastoma: its effects on mitochondrial mediated 
apoptosis, activation of different caspases, G0/G1 cell cycle 
arrest and targeting JNK/p38 MAPK signal pathways. J 
BUON, 24 (2019) 2141.  
13 Schöning V, Hammann F, Peinl M & Drewe J, Editor’s 
Highlight: Identification of Any Structure-Specific 
Hepatotoxic Potential of Different Pyrrolizidine Alkaloids 
Using Random Forests and Artificial Neural Networks. 
Toxicol Sci, 160 (2017) 361. 
14 Alves V, Muratov E, Capuzzi S, Politi R, Low Y, Braga R, 
Zakharov AV, Sedykh A, Mokshyna E, Farag S, Andrade C, 
Kuz'min V, Fourches D & Tropsha A, Alarms about 
structural alerts. Green Chem, 18 (2016) 4348. 
15 Raies AB & Bajic VB, In silico toxicology: computational 
methods for the prediction of chemical toxicity. Wiley 
Interdiscip Rev Comput Mol Sci, 6 (2016) 147. 
16 Benfenati E, Manganaro A & Gini G, VEGA-QSAR: AI 
inside a platform for predictive toxicology. In: CEUR 
Workshop Proceedings (Eds. Baldoni M, Chesani F, Mello P 
& Montali M; CEUR-WS.org), 2013, 1107. 
17 Vargas-Rondón N, Villegas VE & Rondón-Lagos M, The 
Role of Chromosomal Instability in Cancer and Therapeutic 
Responses. Cancers (Basel), 10 (2017) E4. 
18 Podrimaj-Bytyqi A, Borovečki A, Selimi Q, Manxhuka-
Kerliu S, Gashi G & Elezaj IR, The frequencies of 
micronuclei, nucleoplasmic bridges and nuclear buds as 
biomarkers of genomic instability in patients with urothelial 
cell carcinoma. Sci Rep, 8 (2018) 17873. 
19 Zhu H, Rusyn I, Richard A & Tropsha A, Use of Cell Viability 
Assay Data Improves the Prediction Accuracy of Conventional 
Quantitative Structure–Activity Relationship Models of Animal 
Carcinogenicity. Environ Health Perspect, 116 (2008) 506. 
20 Di Sotto A, Di Giacomo S, Abete L, Bozovic M, Barile F, 
Vitalone A, Izzo AA, Ragno R, Parisi AO & Mazzanti G, 
Genotoxicity assessment of piperitenone oxide: An in vitro and 
in silico evaluation. Food Chem Toxicol, 106 (2017) 506. 
21 Loiodice S, Nogueira da Costa A & Atienzar F, Current trends 
in in silico, in vitro toxicology, and safety biomarkers in early 
drug development. Drug Chem Toxicol, 42 (2019) 113. 
22 Gooderham NJ, Cohen SM, Eisenbrand G, Fukushima S, 
Guengerich FP, Hecht SS, Rietjens IMCM, Rosol TJ,  
Bastaki M, Linman MJ & Taylor SV, The safety evaluation 
of food flavoring substances: the role of genotoxicity studies. 
Crit Rev Toxicol, 50 (2020) 1. 
23 Mayer C, Popanda O, Zelezny O, von Brevern MC, Bach A, 
Bartsch H & Schmezer P, DNA repair capacity after gamma-
irradiation and expression profiles of DNA repair genes in 
resting and proliferating human peripheral blood lymphocytes. 
DNA Repair (Amst), 1 (2002) 237. 
24 Hu Q, Xie Y, Ge Y, Nie X, Tao J & Zhao Y, Resting T cells 
are hypersensitive to DNA damage due to defective DNA 
repair pathway. Cell Death Dis, 9 (2018) 662. 
25 Strober W, Trypan Blue Exclusion Test of Cell Viability. In: 
Current Protocols in Immunology, (John Wiley & Sons Inc., 
New Jersey), 2015, A3.B.1. 
26 Singh NP, McCoy MT, Tice RR & Schneider EL, A simple 
technique for quantitation of low levels of DNA damage in 
individual cells. Exp Cell Res, 175 (1988) 184. 
27 Fenech M, The in vitro micronucleus technique. Mutat Res, 
455 (2000) 81. 
28 Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S 
& Zeiger E, HUMN project: detailed description of the scoring 
criteria for the cytokinesis-block micronucleus assay using 
isolated human lymphocyte cultures. Mutat Res, 534 (2003) 65. 
29 Carnat A, Fraisse D, Carnat A-P, Felgines C, Chaud D & 
Lamaison J-L, Influence of drying mode on iridoid bitter 
constituent levels in gentian root. J Sci Food Agric, 85 
(2005) 598. 
30 Chen B, Peng Y, Wang X, Li Z & Sun Y, Preparative 
Separation and Purification of Four Glycosides from 
Gentianae radix by High-Speed Counter-Current 
Chromatography and Comparison of Their Anti-NO 
Production Effects. Molecules, 22 (2017) 2002. 
31 Xu Y, Li Y, Maffucci K, Huang L & Zeng R, Analytical 
Methods of Phytochemicals from the Genus Gentiana. 
Molecules, 22 (2017) 2080. 
32 Bausinger J & Speit G, DNA repair capacity of cultured 
human lymphocytes exposed to mutagens measured by the 
comet assay and array expression analysis. Mutagenesis, 30 
(2015) 811. 
33 Fellows MD, O'Donovan MR, Lorge E & Kirkland D, 
Comparison of different methods for an accurate assessment 
of cytotoxicity in the in vitro micronucleus test. II: Practical 
aspects with toxic agents. Mutat Res, 655 (2008) 4. 
34 Nastasijević B, Milošević M, Janjić G, Stanić V & Vasić V, 
Gentiana lutea extracts and their constituents as inhibitors of 
synaptosomal Ecto-NTPDase. Int J Pharmacol, 12 (2016) 
272. 
35 Krishnamurthy PT, Vardarajalu A, Wadhwani A & Patel V, 
Identification and characterization of a potent anticancer 
fraction from the leaf extracts of Moringa oleifera L. Indian J 
Exp Biol, 53 (2015) 98. 
36 Khan HJ, Ahmad MK, Khan AR, Rastogi N, Mahdi AA, 
Ansari JA, Fatima N & Satyanarayan GNV, Identification of 
Anticancer and Antioxidant phytoconstituents from chloroform 
fraction of Solanum nigrum L. berries using GC-MS/MS 
analysis. Indian J Exp Biol, 54 (2016) 774. 
37 Mihailovic V, Matic S, Misic D, Solujic S, Stanic S, Katanic J, 
Mladenovic M & Stankovic N, Chemical composition, 
antioxidant and antigenotoxic activities of different fractions of 
Gentiana asclepiadea L. roots extract. Excli j, 12 (2013) 807. 
38 Hudecova A, Hasplova K, Miadokova E, Magdolenova Z, 
Rinna A, Collins AR, Galova E, Vaculcikova D, Gregan F & 
Dusinska M, Gentiana asclepiadea protects human cells 
against oxidation DNA lesions. Cell Biochem Funct, 30 
(2012) 101. 
39 Golbamaki A, Benfenati E, Golbamaki N, Manganaro A, 
Merdivan E, Roncaglioni A & Gini G, New clues on 
carcinogenicity-related substructures derived from mining 
two large datasets of chemical compounds. J Environ Sci 
Health C Environ Carcinog Ecotoxicol Rev, 34 (2016) 97. 
40 Zhang L, Ai H, Chen W, Yin Z, Hu H, Zhu J, Zhao J, Zhao Q & 
Liu H, CarcinoPred-EL: Novel models for predicting the 
carcinogenicity of chemicals using molecular fingerprints 
and ensemble learning methods. Sci Rep, 7 (2017) 2118. 
41 Perestrelo R, Silva C, Fernandes MX & Câmara JS, 
Prediction of Terpenoid Toxicity Based on a Quantitative 
Structure-Activity Relationship Model. Foods, 8 (2019) 
E628. 
